HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noa Kremer Selected Research

Rituximab (Mabthera)

4/2019Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noa Kremer Research Topics

Disease

2Bullous Pemphigoid (Pemphigoid)
01/2021 - 04/2019
1Pain (Aches)
04/2022
1Hidradenitis Suppurativa
01/2022
1Eczema
11/2020
1Skin Neoplasms (Skin Cancer)
11/2020
1Measles
10/2020
1Solar Urticaria
07/2018
1Hypertension (High Blood Pressure)
10/2017

Drug/Important Bio-Agent (IBA)

2Omalizumab (Xolair)FDA Link
04/2019 - 07/2018
1TetracyclinesIBA
04/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2020
1Measles VaccineIBA
10/2020
1VaccinesIBA
10/2020
1Rituximab (Mabthera)FDA Link
04/2019
1Metformin (Glucophage)FDA LinkGeneric
10/2017

Therapy/Procedure

1Photochemotherapy (Photodynamic Therapy)
11/2020
1Therapeutics
10/2017